The ability to survive stage II pancreatic cancer has shifted from a statistical improbability to a documented possibility for some patients through the use of personalized mRNA vaccines. While standard care typically relies on a combination of surgery and chemotherapy, a clinical trial at Memorial Sloan Kettering Cancer Center demonstrated that reprograming a patient's own immune system to recognize mutant proteins on cancer cells can lead to long-term remission. The Mechanism of Personalized Immunotherapy Unlike traditional vaccines that prevent infection, these mRNA treatments are therapeutic. The process begins with a biopsy of the patient's tumor; researchers then use genomics and AI to decode the specific mutations of that cancer. This data is used to create a custom mRNA sequence that trains the immune system to mass-produce cancer-attacking cells. In a small trial of 16 patients with pancreatic cancer, the vaccine was effective in half of the participants. For those who responded, such as Donna Gustafson, the immune response was not only powerful-showing a 10,000-fold increase in specific immune cells-but durable, lasting years after the final dose was administered.

Biomolecular condensates control key cellular processes, from gene expression to signal transduction, by organizing molecules through selective compartmentalization. Increasing evidence links their dysregulation to cancer, neurodegeneration, and other diseases, positioning condensates as promising therapeutic targets. This review explores emerging strategies that go beyond dissolving pathological condensates, including approaches that induce, redirect, or reprogram their dynamics, composition, and physical state. Rather than inhibiting individual proteins, these interventions reshape the cellular organization itself. By targeting the material and functional properties of condensates, such strategies offer a new conceptual framework for therapeutic design in complex, dysregulated biological systems.

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne...

Read the full paper: β-catenin-driven innate and metabolic reprograming in macrophages fuel T-cell-dependent inflammation in Toxoplasma gondii infection: implications for therapeutic intervention

Biomolecular condensates control key cellular processes, from gene expression to signal transduction, by organizing molecules through selective compartmentalization. Increasing evidence links their dysregulation to cancer, neurodegeneration, and other diseases, positioning condensates as promising therapeutic targets. This review explores emerging strategies that go beyond dissolving pathological condensates, including approaches that induce, redirect, or reprogram their dynamics, composition, and physical state. Rather than inhibiting individual proteins, these interventions reshape the cellular organization itself. By targeting the material and functional properties of condensates, such strategies offer a new conceptual framework for therapeutic design in complex, dysregulated biological systems.

Listen and make your own on Suno.

Listen and make your own on Suno.

Multiple epigenetic layers including DNA methylation, histone modifications, and RNA methylation coordinate to precisely control gene expression during bam